72 related articles for article (PubMed ID: 9739577)
1. Pharmacological prevention of relapse.
Lader M
Kaohsiung J Med Sci; 1998 Jul; 14(7):448-57. PubMed ID: 9739577
[TBL] [Abstract][Full Text] [Related]
2. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
3. Maintenance therapy of persons with schizophrenia.
Carpenter WT
J Clin Psychiatry; 1996; 57 Suppl 9():10-8. PubMed ID: 8823345
[TBL] [Abstract][Full Text] [Related]
4. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
5. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
6. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
Csernansky JG; Mahmoud R; Brenner R;
N Engl J Med; 2002 Jan; 346(1):16-22. PubMed ID: 11777998
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
Schooler NR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
[TBL] [Abstract][Full Text] [Related]
8. Prevention of relapse in chronic schizophrenic patients.
Hogarty GE
J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
[TBL] [Abstract][Full Text] [Related]
9. Partial compliance with antipsychotics and its impact on patient outcomes.
Narasimhan M; Un Pae C; Masand N; Masand P
Int J Psychiatry Clin Pract; 2007; 11(2):102-11. PubMed ID: 24937555
[TBL] [Abstract][Full Text] [Related]
10. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
11. The natural course of schizophrenia and effective maintenance drug treatment.
Davis JM; Andriukaitis S
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
[TBL] [Abstract][Full Text] [Related]
12. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
13. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
[TBL] [Abstract][Full Text] [Related]
14. Dose response of prophylactic antipsychotics.
Davis JM; Kane JM; Marder SR; Brauzer B; Gierl B; Schooler N; Casey DE; Hassan M
J Clin Psychiatry; 1993 Mar; 54 Suppl():24-30. PubMed ID: 8097195
[TBL] [Abstract][Full Text] [Related]
15. New drugs for schizophrenia: an update for family physicians.
Amadio PB; Cross LB; Amadio P
Am Fam Physician; 1997 Sep; 56(4):1149-56, 1159-60. PubMed ID: 9310066
[TBL] [Abstract][Full Text] [Related]
16. Management strategies for the treatment of schizophrenia.
Kane JM
J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
19. The importance of treatment acceptability to patients.
Naber D; Kasper S
Int J Psychiatry Clin Pract; 2000; 4(1):25-34. PubMed ID: 24927307
[TBL] [Abstract][Full Text] [Related]
20. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
Rummel-Kluge C; Schuster T; Peters S; Kissling W
Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
